These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25936494)

  • 1. Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent.
    La Manna A; Mangiameli A; Capodanno D; Longo G; Sgroi C; Tamburino C
    Can J Cardiol; 2015 May; 31(5):691.e1-3. PubMed ID: 25936494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold.
    Mangiameli A; Ohno Y; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Apr; 8(4):633-4. PubMed ID: 25819179
    [No Abstract]   [Full Text] [Related]  

  • 3. Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis?
    Kilic ID; Konstantinidis N; Pighi M; Mattesini A; Di Mario C
    Cardiovasc Revasc Med; 2015 Mar; 16(2):124-6. PubMed ID: 25130791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge.
    Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C
    JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stent-induced left anterior descending coronary artery aneurysm: repair by pericardial patch--where are we headed?
    Luthra S; Tatoulis J; Warren RJ
    Ann Thorac Surg; 2007 Apr; 83(4):1530-2. PubMed ID: 17383377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Aneurysm After Bioresorbable Vascular Scaffold Implantation With Post-Dilation: Is Less More?
    Meincke F; Reinholz C; Spangenberg T; Wienemann H; Arjomand A; Kreidel F; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2017 Jan; 10(1):96-97. PubMed ID: 28017314
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late coronary BVS malapposition and aneurysm: A Time for Appraisal.
    Cortese B; Silva Orrego P; Virmani R
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):678-81. PubMed ID: 25504909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful placement of a stent in a previously treated un-stentable vessel segment, made possible by the ACS Hi-Torque Wiggle Wire: a case report.
    Simons AJ; Caputo RP; Gaimbartolomei A
    J Invasive Cardiol; 2004 Jan; 16(1):28; discussion 29-30. PubMed ID: 14699220
    [No Abstract]   [Full Text] [Related]  

  • 14. Late target lesion revascularization after implantation of sirolimus-eluting stent.
    Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
    Miyazaki T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).
    Lanjewar CP; Sharma A; Sheth T
    J Invasive Cardiol; 2009 May; 21(5):E87-90. PubMed ID: 19411733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary graft angioplasty guided by MSCT: an unexpected ostial stent deformation.
    Pesenti Rossi D; Caussin C; Baron N; Fourme T; Livarek B
    Eur Heart J Cardiovasc Imaging; 2013 Apr; 14(4):308. PubMed ID: 23103947
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Outcomes After Treatment with ELCA for In-Stent Restenosis of DES.
    Nakamura F; Amaki T; Fukino K
    Int Heart J; 2018; 59(1):1-2. PubMed ID: 29375109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.